Nearly a third of FDA-approved drugs had problems, study finds

Among 222 FDA-approved novel therapeutics, there were 123 postmarket safety events. Bextra was among those taken off the market.

Story highlights

  • Seventy-one novel therapeutics approved from 2001 to 2010 had postmarket safety events
  • 3 were withdrawn, 61 got boxed warnings, 59 required safety communications
  • Experts say study shows the benefits of monitoring drug safety

(CNN)Patients might think the US Food and Drug Administration's stamp of approval means that a produc